Radiological Evaluation after Treatment of Hepatocellular Carcinoma: Criteria and Application

WANG Wenjun,ZHAO Yan,HAN Guohong
DOI: https://doi.org/10.3969/j.issn.1001-5256.2016.01.009
2016-01-01
Abstract:An early and accurate response evaluation is essential for clinicians to decide whether to continue the treatment with current therapeutic regimen or to make necessary changes. This article briefly introduces the development of response evaluation criteria for tumors, elaborates on the application of radiological evaluation criteria in local interventional therapy or sorafenib treatment of hepatocellular carcinoma (HCC), compares the four radiological evaluation criteria, i.e., World Health Organization (WHO) criteria, Response Evaluation Criteria in Solid Tumors (RECIST), European Association for the Study of Liver (EASL) criteria, and the modified RECIST (mRECIST), and thinks that EASL criteria and mRECIST are better than WHO criteria and RECIST and can predict the prognosis of HCC patients at earlier time points.
What problem does this paper attempt to address?